In this work, orthotopic transplantation of PyMT tumor cells demonstrated that SF-RON loss increased TCF1+ CD4+ T-cells in metastatic lesions, which prevented outgrowth as well as an increase in the CD8+ T-cells which mediated the killing of metastatic cells [12]. The gene discussed is CD8A; the disease is neoplasm.